Bliss GVS Pharma (BLISSGVS) Share Price Rises 5% to Rs 676.75 Today
- October 12, 2026
- Posted by: Kunal Singla
- Category: News
Bliss GVS Pharma Share Price moved higher today, with the stock trading at Rs 676.75, up 5% from the previous close of Rs 644.55 and valuing the company at Rs 6,853.53 Cr. Univest data confirms the move itself, though no company-specific trigger has been identified. The move makes Bliss GVS Pharma Share Price a key stock news item in the Indian stock market this morning because the price action is clear, while the reason for the gain is not verified. For readers tracking Bliss GVS Pharma Share Price Today, the important context is the combination of a fresh share price gain, a market capitalisation well above the industry median in the latest Univest figures, and a valuation profile that sits above the broader healthcare benchmark. Investors watching Bliss GVS Pharma Stock News can also compare the move with its P/E, P/B, ROE and ROCE in the sections below.
Bliss GVS Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 676.75 |
| Previous Close | Rs 644.55 |
| Today's Move | Rs 32.2 (+5%) |
| Open | Rs 658 |
| High | Rs 676.75 |
| Low | Rs 658 |
| Market Capitalisation | Rs 6,853.53 crore |
| Market Cap Category | Mid Cap |
Bliss GVS Pharma Ltd. (BLISSGVS) rose to Rs 676.75 from the previous close of Rs 644.55, a move of Rs 32.2 or 5%. The stock opened at Rs 658, reached a high of Rs 676.75, recorded a low of Rs 658.
Bliss GVS Pharma Share Price showed a firm intraday rise, opening at Rs 658 and moving to Rs 676.75, where it also touched the day high. The day low was Rs 658, which means the stock stayed within a tight range around the opening level while still registering a 5% gain over the previous close. Bliss GVS Pharma Share Price Today therefore reflects a clear upward move in price action rather than a broad trading range expansion. The stock’s day change was Rs 32.2, and the latest Univest figures place the market capitalisation at Rs 6,853.53 Cr. On a live basis, Bliss GVS Pharma Share Price Live action remains relevant for anyone following Bliss GVS Pharma Share Price Update, because the move is measurable and current even though the event catalyst is not established. That leads naturally into the company’s fundamental profile.
Bliss GVS Pharma Ltd. (BLISSGVS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 6,853.53 crore |
| P/E Ratio | 50.32x |
| P/B Ratio | 5.56x |
| ROE | 12.11% |
| ROCE | 17.4% |
| EPS | Rs 12.81 |
| Book Value Per Share | Rs 115.94 |
| Dividend Yield | 0.23% |
Bliss GVS Pharma Ltd. (BLISSGVS) fundamental metrics show P/E 50.32x, P/B 5.56x, ROE 12.11%, ROCE 17.4%. Read together, these ratios describe the company’s position rather than a recommendation.
Bliss GVS Pharma Ltd. has a market capitalisation of Rs 6,853.53 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 50.32x, P/B at 5.56x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.11% and ROCE of 17.4%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 12.81, book value per share of Rs 115.94, dividend yield of 0.23%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.5x, median ROE of 11.22%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 50.32x |
| Benchmark Median P/E | 31.5x |
| Benchmark Average P/E | 47.12x |
| Benchmark P/E Range | 3.56x to 679.32x |
| Company P/B Ratio | 5.56x |
| Benchmark Median P/B | 2.83x |
| Company ROE | 12.11% |
| Benchmark Median ROE | 11.22% |
| Company ROCE | 17.4% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 6,853.53 crore |
| Benchmark Median Market Cap | Rs 709.64 crore |
Bliss GVS Pharma Ltd. (BLISSGVS) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Bliss GVS Pharma Ltd. (BLISSGVS) has a P/E ratio of 50.32x, which is above the benchmark median of 31.5x, a difference of +59.75%. The P/E comparison frames valuation; it is not a signal to buy or sell.
Bliss GVS Pharma Ltd. (BLISSGVS) has a ROE of 12.11%, which is above the benchmark median of 11.22%, a difference of +7.93%. Bliss GVS Pharma Ltd. (BLISSGVS) has a ROCE of 17.4%, which is above the benchmark median of 13.1%, a difference of +32.82%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,21,539.16 | 34.85 | 4.87 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,47,576 | 84.64 | 14.02 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,77,251.42 | 81.27 | 19.75 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,231.65 | 24.65 | 4.13 | 19.69 | 21.39 |
| Laurus Labs Ltd. | LAURUSLABS | 1,09,796.85 | 100.42 | 19.47 | 18.31 | 18.2 |
Bliss GVS Pharma Ltd. (BLISSGVS) has a P/E ratio of 50.32x compared with the displayed peer median of 81.27x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 12.11% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 17.4% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Bliss GVS Pharma Ltd. (BLISSGVS) has a market capitalisation of Rs 6,853.53 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Bliss GVS Pharma
- Bliss GVS Pharma Share Price rose 5% today to Rs 676.75, giving the stock a clear intraday share price gain.
- Bliss GVS Pharma Share Price is being measured against a P/E of 50.32 and P/B of 5.56, both above the industry median.
- ROE of 12.11% and ROCE of 17.4% place Bliss GVS Pharma Share Price above the same-industry median on profitability.
- The market capitalisation of Rs 6,853.53 Cr keeps Bliss GVS Pharma Share Price well above the benchmark median company size.
- Univest data shows that the price event is real, while the company-specific catalyst is not established.
About Bliss GVS Pharma
Bliss GVS Pharma Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The company is followed for its share price movement, market cap, valuation ratios and profitability metrics on Univest. In the current analysis, Bliss GVS Pharma Share Price is being viewed alongside EPS of Rs 12.81, book value of Rs 115.94 and dividend yield of 0.23%, which together help frame how the business is priced relative to its accounting base and earnings profile. The stock’s position in the pharma space makes it relevant to investors who compare company financials, market capitalisation and peer comparison rather than focusing only on one-day price action. For Bliss GVS Pharma Share Price Today, the main point is simple: the market has marked the stock higher, and the fundamental picture provides context for that move.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
1. Why is Bliss GVS Pharma Share Price rising today?
Ans. Bliss GVS Pharma Share Price is rising today by 5% to Rs 676.75. According to Univest data, the price event is confirmed, but no company-specific catalyst is established, so the move should be read as verified price action only.
2. What is Bliss GVS Pharma Share Price today?
Ans. Bliss GVS Pharma Share Price today is Rs 676.75. It is up Rs 32.2 from the previous close of Rs 644.55, and the stock’s market capitalisation stands at Rs 6,853.53 Cr.
3. How much did Bliss GVS Pharma share price gain?
Ans. Bliss GVS Pharma Share Price gained 5% in the current move. The stock opened at Rs 658 and touched a high of Rs 676.75, which is also the latest traded price in the article timestamp.
4. What is the market capitalisation of Bliss GVS Pharma?
Ans. Bliss GVS Pharma has a market capitalisation of Rs 6,853.53 Cr. In the same industry benchmark, the median market cap is Rs 709.64 Cr, so the company sits above the benchmark middle.
5. What does Bliss GVS Pharma Fundamental Analysis show?
Ans. Bliss GVS Pharma Fundamental Analysis shows a P/E of 50.32, P/B of 5.56, ROE of 12.11%, ROCE of 17.4%, EPS of Rs 12.81 and book value of Rs 115.94. The numbers give valuation and profitability context.
6. How does Bliss GVS Pharma compare with sector benchmarks?
Ans. Bliss GVS Pharma compares with a sector median P/E of 31.5 and median P/B of 2.83. Its ROE of 12.11% and ROCE of 17.4% are above the benchmark medians of 11.22% and 13.1%.
7. What is the dividend yield of Bliss GVS Pharma?
Ans. Bliss GVS Pharma has a dividend yield of 0.23%. That figure is best read alongside its share price, book value of Rs 115.94 and P/E ratio of 50.32 rather than in isolation.
8. Which peers are useful for Bliss GVS Pharma Share Price comparison?
Ans. Useful peers for Bliss GVS Pharma Share Price comparison include Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Laurus Labs. They provide a wide range of valuation and profitability reference points.
Track Bliss GVS Pharma Share Price on Univest
Use Bliss GVS Pharma Ltd. (BLISSGVS) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Track Bliss GVS Pharma Share Price on Univest to follow live share price movement, fundamental ratios, 52-week levels and market insights in one place. Univest also helps you compare Bliss GVS Pharma Stock News with peer valuations, sector analysis and company overview details as they evolve through the day. If you are monitoring Bliss GVS Pharma Share Price Update, the platform gives a structured way to review price action, fundamentals and industry context together.
